Results 181 to 190 of about 116,451 (242)

Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis. [PDF]

Eur J Neurol
Habib AA, Benatar M, Vu T, Meisel A, Attarian S, Katsuno M, Liao S, Beasley KN, Howard JF.   +8 more
europepmc   +1 more source

Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-blind, placebo-controlled trial. [PDF]

Muscle Nerve
Bril V, Berkowicz T, Szczudlik A, Nicolle MW, Bednarik J, Hon P, Vaitkus A, Vu T, Rozsa C, Magnus T, Panczel G, Toomsoo T, Pasnoor M, Mozaffar T, Freimer M, Reuner U, Vécsei L, Souayah N, Levine T, Pascuzzi RM, Dalakas MC, Rivner M, Griffin R, Coll MQ, Mondou E.   +24 more
europepmc   +1 more source

Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment. [PDF]

Eur J Neurol
Gilhus NE, Andersen H, Andersen LK, Boldingh M, Laakso S, Leopoldsdottir MO, Madsen S, Piehl F, Popperud TH, Punga AR, Schirakow L, Vissing J.   +11 more
europepmc   +1 more source

Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M₅ Muscarinic Acetylcholine Receptor. [PDF]

J Med Chem
Li J, Orsi DL, Engers JL, Long MF, Capstick RA, Maurer MA, Presley CC, Vinson PN, Rodriguez AL, Han A, Cho HP, Chang S, Jackson M, Bubser M, Blobaum AL, Boutaud O, Nader MA, Niswender CM, Conn PJ, Jones CK, Lindsley CW, Han C.   +21 more
europepmc   +1 more source

[¹¹C]MK-6884 PET imaging reveals lower M₄ muscarinic acetylcholine receptor availability following cocaine self-administration in male rats. [PDF]

Pharmacol Rep
Gollapelli KK, Krizan I, Bhoopal B, Damuka N, Moriarty C, Miller M, Sai KKS, Gould RW.   +7 more
europepmc   +1 more source

Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM). [PDF]

ACS Chem Neurosci
Engers JL, Baker LA, Chang S, Luscombe VB, Rodriguez AL, Niswender CM, Cho HP, Bubser M, Gray AT, Jones CK, Peng W, Rook JM, Bridges TM, Boutaud O, Conn PJ, Engers DW, Lindsley CW, Temple KJ.   +17 more
europepmc   +1 more source

Potentiation of the muscarinic acetylcholine receptor 1 modulates neurophysiological features in a mouse model of Rett syndrome. [PDF]

Neurotherapeutics
Dong HW, Weiss K, Baugh K, Meadows MJ, Niswender CM, Neul JL.   +5 more
europepmc   +1 more source

Nicotinic Acetylcholine Receptor Alpha6 Contributes to Antiviral Immunity via IMD Pathway in Drosophila melanogaster. [PDF]

Viruses
Wang Z, Lin X, Shi W, Cao C.
europepmc   +1 more source

Mechanism of hydrophobic gating in the acetylcholine receptor channel pore. [PDF]

J Gen Physiol
Kumari M, Khatoon N, Sharma R, Adusumilli S, Auerbach A, Kashyap HK, Nayak TK.   +6 more
europepmc   +1 more source

Single Amino Acid Substitution in Loop1 Switches the Selectivity of α-Conotoxin RegIIA towards the α7 Nicotinic Acetylcholine Receptor. [PDF]

Mar Drugs
Yu J, Xie J, Ma Y, Wei P, Zhang P, Tang Z, Zhu X, Zhangsun D, Luo S.   +8 more
europepmc   +1 more source